Home » GUIDANT ANNOUNCES ENROLLMENT OF FIRST PATIENT IN LANDMARK CAROTID ARTERY STENTING STUDY
GUIDANT ANNOUNCES ENROLLMENT OF FIRST PATIENT IN LANDMARK CAROTID ARTERY STENTING STUDY
Guidant Corporation today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in high surgical risk patients, called CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). WebWire (http://webwire.com/ViewPressRel.asp?SESSIONID=&aId=11244)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May